Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 3 institutions in 1 country.
Martina KubovcikovaInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.ORCID 0000-0001-7672-7116
Radka SobotovaInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.
Vlasta ZavisovaInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.
Iryna AntalInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.
Iryna KhmaraInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.
Maksym LisnichukFaculty of Science, Pavol Jozef Safarik University, Park Angelinum 9, 04001 Kosice, Slovakia.ORCID 0000-0002-0975-2060
Zuzana BednarikovaInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.ORCID 0000-0003-0837-9564
Alena JurikovaInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.
Oliver StrbakJessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, 03601 Martin, Slovakia.ORCID 0000-0002-0212-3392
Jana VojtovaJessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, 03601 Martin, Slovakia.ORCID 0000-0002-0759-8696
Pavol MikolkaJessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, 03601 Martin, Slovakia.ORCID 0000-0001-8485-4748
Jan GombosJessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, 03601 Martin, Slovakia.
Alica LokajovaJessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, 03601 Martin, Slovakia.
Zuzana GazovaInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.ORCID 0000-0002-0670-3431
Martina KonerackaInstitute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001 Kosice, Slovakia.ORCID 0000-0002-2098-070X
Slovak Academy of Sciences · SKComenius University Bratislava · SKUniversity of Pavol Jozef Šafárik · SK
Funding
he Operational Program Integrated Infrastructure funded by the ERDF ITMS2014+ 313011T553 "DIAGNAD" ITMS: 313011AVG3 "BIOVID"Operational Programme Integrated Infrastructure co-funded by ERDF ITMS 313011AVG3Slovak Grant Agency EGA 02/0176/21, VEGA 02/0164/22, VEGA 02/0049/23The application of spectroscopic methods for early, non-invasive real-time identification of selected diseases using gasses released from lungs and skin IMTS: 313011BWX6the Slovak Research and Development Agency APVV-18-0284, APVV SK-TW-21-0004
6 · The paper itself
Abstract
Acute respiratory distress syndrome (ARDS) is a life-threatening condition characterized by the rapid onset of lung inflammation Therefore, monitoring the spatial distribution of the drug directly administered to heterogeneously damaged lungs is desirable. In this work, we focus on optimizing the drug
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.